Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |